About: The pathogenesis and treatment of the `Cytokine Storm' in COVID-19

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 10 April 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2020 (fr) artículu científicu espublizáu n'abril de 2020 (ast) 2020 թվականի ապրիլի 10-ին հրատարակված գիտական հոդված (hy) scientific article published on 10 April 2020 (en) наукова стаття, опублікована 10 квітня 2020 (uk)
publication date	wds:Q91240147-61C703A8-FE39-4D1B-997F-6956C9D96467 wds:Q91240147-9E0663E4-CF65-4BED-B58F-A6802DEC2D9B
publication date	2020-04-10 00:00:00Z (xsd:dateTime) 2020-06-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q91240147-0532313B-884A-40F1-85AB-E825505B81B6 wds:Q91240147-8E826757-5DAD-4E07-89D3-0650FFD5FFC1 wds:Q91240147-E1FD43A0-5D0C-42DC-82D8-4A8C2E09FAE0
author name string	Qing Ye Jianhua Mao Bili Wang
rdfs:label	The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 (en) The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 (nl)
skos:prefLabel	The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 (en) The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 (nl)
name	The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 (en) The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 (nl)
title	wds:Q91240147-41928DFD-126C-4A4B-BF91-14C36E7520BD
title	The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 (en)
instance of	wds:Q91240147-47a66024-1013-454e-8327-f4e6fd7f3af1 wds:Q91240147-55CC2B32-637D-4E72-8A8D-75126E9A438B
instance of	review article scholarly article
main subject	wds:Q91240147-46A1EDF9-C7BD-4978-A8A1-37034E33223D wds:Q91240147-514E1437-5AEB-4C3C-BF64-33EE8E221156 wds:Q91240147-A2FF12BA-F96E-4AB5-A3EA-5CAF2E5C9F31
main subject	SARS-CoV-2 COVID-19 mortality cytokine storm
PubMed ID	wds:Q91240147-2714D36F-9B8D-4774-9632-EA604778E942
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32283152
PubMed ID	32283152
published in	wds:Q91240147-113508BC-2624-456B-9D35-88F222F38651
published in	Journal of Infection
DOI	wds:Q91240147-5E9BB5F8-F308-477E-816C-97863EE1C6FC
DOI	http://dx.doi.org/10.1016/J.JINF.2020.03.037
DOI	10.1016/J.JINF.2020.03.037
Semantic Scholar corpus ID	wds:Q91240147-A84DC0C9-04BA-43B3-922A-D6C6F1B2FA01
Semantic Scholar corpus ID	218466307
Dimensions Publication ID	wds:Q91240147-4694F88D-0263-4E7E-9E98-9EC0E23C8533
Dimensions Publication ID	1126594667
PMCID	wds:Q91240147-514E5714-9441-45FA-9274-165022EAD3C1
PMCID	7194613
COVIDWHO ID	wds:Q91240147-24D6D52A-E8E4-411D-A97B-37C12596358A wds:Q91240147-7DC82805-EE96-4E43-8377-2C760179C304
COVIDWHO ID	covidwho-45863 covidwho-45864
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91240147
is cites work of	Appropriate use of Tocilizumab in COVID-19 Infection Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study A CASE REPORT OF COVID-19 ASSOCIATED HYPERACTIVE ICU DELIRIUM WITH PROPOSED PATHOPHYSIOLOGY AND TREATMENT Can Zn Be a Critical Element in COVID-19 Treatment? Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection COVID-19: dealing with a potential risk factor for chronic neurological disorders Is Sex a Determinant of COVID-19 Infection? Truth or Myth? Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan, China Could SARS-CoV-2-Induced Hyperinflammation Magnify the Severity of Coronavirus Disease (CoViD-19) Leading to Acute Respiratory Distress Syndrome? Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - achieving global consensus and visibility for cellular host-directed therapies Cannabidiol Modulates Cytokine Storm in Acute Respiratory Distress Syndrome Induced by Simulated Viral Infection Using Synthetic RNA COVID-19 associated complications and potential therapeutic targets COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons Cell type-specific immune dysregulation in severely ill COVID-19 patients Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs Potential Applications of Nanomaterials to Quench the Cytokine Storm in Coronavirus Disease 19 The value of serum amyloid A for predicting the severity and recovery of COVID-19 Clinical Characteristics and Risk Factors for Disease Severity and Death in Patients With Coronavirus Disease 2019 in Wuhan, China Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis COVID-19 in diabetic patients: related risks and specifics of management Safety and COVID-19 Symptoms in Individuals Recently Vaccinated with BCG: a Retrospective Cohort Study Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients COVID-19: A tocsin to our aging, unfit, corpulent, and immunodeficient society Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a Eicosanoids: the Overlooked Storm in COVID-19? An Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy? An overview of the pathogenic mechanisms involved in severe cases of COVID-19 infection, and the proposal of salicyl-carnosine as a potential drug for its treatment Prevention of Severe Coronavirus Disease 2019 Outcomes by Reducing Low-Grade Inflammation in High-Risk Categories Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture SARS-CoV-2 (Covid-19): Interferon-epsilon may be responsible of decreased mortality in females Can vitamins and/or supplements provide hope against coronavirus? Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19) Supplements for COVID-19: A modifiable environmental risk Coronavirus 2019, Microthromboses, and Platelet Activating Factor SARS-CoV-2 infection among patients with systemic autoimmune diseases Perspectives of Immune Therapy in Coronavirus Disease 2019 Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software